ERBB2 and neoplasm: The generated CAR-macrophages specifically recognized the cognate CD19, CD22 or HER2 antigens, phagocytosed antigen-bearing tumor cells, cross-presented tumor antigens, provided T-cell costimulation and inhibited tumor growth in vitro.